{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:46:53Z","timestamp":1792568813908,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.rmed.2019.01.016","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T11:32:57Z","timestamp":1549020777000},"page":"49-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["Mepolizumab improves small airway function in severe eosinophilic asthma"],"prefix":"10.1016","volume":"148","author":[{"given":"Claude S.","family":"Farah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Badal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory G.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Thamrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh M.","family":"Seccombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2019.01.016_bib1","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0140-6736(02)11679-5","article-title":"Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial","volume":"360","author":"Green","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2019.01.016_bib2","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/S0140-6736(00)03496-6","article-title":"Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response","volume":"356","author":"Leckie","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2019.01.016_bib3","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1067\/mai.2003.1382","article-title":"Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics","volume":"111","author":"Menzies-Gow","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.01.016_bib4","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma","volume":"360","author":"Haldar","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2019.01.016_bib5","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"For the MENSA Investigators. Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2019.01.016_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaci.2012.02.015","article-title":"Ventilation heterogeneity predicts asthma control in adults following inhaled corticosteroid dose titration","volume":"130","author":"Farah","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.01.016_bib7","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1164\/ajrccm.163.7.2008013","article-title":"Distal lung dysfunction at night in nocturnal asthma","volume":"163","author":"Kraft","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2019.01.016_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0091-6749(97)70193-3","article-title":"Inflammation of small airways in asthma","volume":"100","author":"Hamid","year":"1997","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.01.016_bib9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1183\/09031936.97.10020292","article-title":"The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics","volume":"10","author":"Carroll","year":"1997","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2019.01.016_bib10","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1164\/ajrccm.159.5.9809017","article-title":"Evidence of acinar airway involvement in asthma","volume":"159","author":"Verbanck","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2019.01.016_bib11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1183\/09031936.00069712","article-title":"Consensus statement for inert gas washout measurement using multiple- and single- breath tests","volume":"41","author":"Robinson","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2019.01.016_bib12","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jaci.2009.10.053","article-title":"Inflammation and airway function in the lung periphery of patients with stable asthma","volume":"125","author":"Verbanck","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.01.016_bib13","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.jaci.2013.01.054","article-title":"Peripheral lung function in patients with stable and unstable asthma","volume":"131","author":"Thompson","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.01.016_bib14","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.rmed.2004.10.008","article-title":"Measurement properties and interpretation of three shortened versions of the asthma control questionnaire","volume":"99","author":"Juniper","year":"2005","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2019.01.016_bib15","first-page":"912","article-title":"ATS\/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide","volume":"171","author":"American Thoracic Society, European Respiratory Society","year":"2005","journal-title":"Am J Respir Crit Care Med 2005"},{"key":"10.1016\/j.rmed.2019.01.016_bib16","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"American Thoracic Society Committee on Interpretation of Exhaled Nitric Oxide Levels for Clinical A. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2019.01.016_bib17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2019.01.016_bib18","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2019.01.016_bib19","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/thx.2006.069682","article-title":"Ventilation heterogeneity is a major determinant of airway hyperresponsiveness in asthma, independent of airway inflammation","volume":"62","author":"Downie","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2019.01.016_bib20","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1378\/chest.130.4.1055","article-title":"Evaluation of asthma with hyperpolarized helium-3 MRI: correlation with clinical severity and spirometry","volume":"130","author":"de Lange","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2019.01.016_bib21","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S2213-2600(17)30125-X","article-title":"Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial","volume":"5","author":"Chupp","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmed.2019.01.016_bib22","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jaci.2015.12.1336","article-title":"Utility of impulse oscillometry in patients with moderate to severe persistent asthma","volume":"138","author":"Jabbal","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.01.016_bib23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.rmed.2016.05.028","article-title":"Clinical characteristics of adult asthma associated with small airway dysfunction","volume":"117","author":"Kjellberg","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2019.01.016_bib24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1164\/rccm.201603-0537LE","article-title":"Toward predicting individual risk in asthma using daily home monitoring of resistance","volume":"195","author":"Gobbi","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2019.01.016_bib25","unstructured":"Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. https:\/\/www.ginasthma.org Date last updated: March 19 2018. Date last accessed: October 23 2018."},{"key":"10.1016\/j.rmed.2019.01.016_bib26","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S2213-2600(13)70182-6","article-title":"Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D-CFTR mutation and preserved spirometry: a randomised controlled trial","volume":"1","author":"Davies","year":"2013","journal-title":"The Lancet Respiratory medicine"},{"key":"10.1016\/j.rmed.2019.01.016_bib27","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jaci.2013.11.026","article-title":"Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis","volume":"133","author":"Haldar","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.01.016_bib28","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","article-title":"Dupilumab in persistent asthma with elevated eosinophil levels","volume":"368","author":"Wenzel","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2019.01.016_bib29","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nature03490","article-title":"Self-organized patchiness in asthma as a prelude to catastrophic shifts","volume":"434","author":"Venegas","year":"2005","journal-title":"Nature"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611119300320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611119300320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:45:50Z","timestamp":1760615150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611119300320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":29,"alternative-id":["S0954611119300320"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2019.01.016","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mepolizumab improves small airway function in severe eosinophilic asthma","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2019.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}